Allison House-Gecewicz

VP Clinical Operations
  • Passionate about developing novel treatment protocols in CNStherapeutics to advance unmet medical needs. Translate business strategy into optimal solutions by building and partnering with premier providers
  • Well networked in developing and nurturing strong Key Opinion Leader (KOL)relationships in Phase I - IV Trials.
  • Extensive background in various therapeutic areas (TAs) with a special emphasis on CNS indications. Experience includes, Alzheimer’s, mild cognitive impairment, schizophrenia (CIAS, negative, and positive symptoms), bipolar disorder (mania and depressive state) and MDD.
  • Significant experience with the unique challenges in phase I (first in human, SAD, MAD, complex cohort management) and orphan indications (Friederichs’s ataxia, behavioral variant FTD, FTD with Progranulin Mutation).
Back to team

Our site uses cookies. Learn more about our privacy policy.

I accept the use of cookies